Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy

NCT05899920 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.

NCT NCT05899920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05899920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy
Lead sponsor
Ryazan State Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
March 11, 2022
Completion date
December 31, 2024
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resistant arterial hypertension